Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2025
Djordje Atanackovic, MD
CD229-targeting CAR T cells as a novel cellular immunotherapy for T cell...
Read More
2025
Chonghui Cheng, MD, PhD
mRNA-based immunotherapy for targeting triple-negative breast cancer
Read More
2025
Britta Will, PhD
Genetic subtype-agnostic differentiation therapy for patients with myeloid malignancies
Read More
2025
Christina Curtis, PhD
Harnessing hereditary and immune interplay for cancer interception
Read More
2025
Ulrich Steidl, MD, PhD
Understanding and Targeting Transcriptional Noise in Chemotherapy Resistance in Acute Myeloid Leukemia
Read More
2025
Jeffrey Magee, MD, PhD
Sphingolipid transport as a novel therapeutic vulnerability in high-risk pediatric AML
Read More
2025
Toshiro Hara, PhD
Decoding Transcriptional and Environmental Regulation of Infiltrative Growth in Pediatric Diffuse Midline...
Read More
2025
Antony Michealraj Kulandai Manuvel, PhD
Integrated epigenetic and metabolic regulation reveal targetable vulnerabilities in pediatric ependymomas
Read More
2025
Brian Czerniecki, MD, PhD
ImmuneHERGAL for Breast Cancer Prevention
Read More
2025
Andras Heczey, MD
In vivo engineered CAR T/NK cells to cure pediatric GPC3+ solid tumors
Read More
2025
Evan Weber, PhD
Uncovering mechanisms of durable CAR-T cell persistence in the bone marrow niche
Read More
2025
Markus Müschen, MD, PhD
Targeting β-catenin protein degradation in high-risk pediatric ALL
Read More
2025
Lillian Guenther, MD
Targeting DDX19A to Initiate Transcriptional Overload in Ewing Sarcoma
Read More
2025
S. John Liu, MD, PhD
Systematic temporally resolved dissection of genetic vulnerabilities to increase the efficacy of...
Read More
2025
Augusto Faria Andrade, PhD
Exploiting the challenging tumour microenvironment of H3-mutant gliomas for therapeutic development
Read More
2025
Sima Ehsani Chimeh, MD
PET-Guided Development of HER2-Targeted Radiopharmaceuticals: From 18F-Labeled Radioligands to 212Pb Radioligand Therapy...
Read More